Clud | Organizaciones | Innovación | Actualidad | Licitaciones
a
a
a
   

Strengthen and develop scientific and technological excellence in research and therapy of leukemia (CML, AML, ALL, CLL, MDS, CMPD) by integration of the leading national leukemia networks and their interdisciplinary partner groups in Europe

  • De fecha: 10/12/2009
    •  
       
     



    0

    Información relacionada con strengthen and develop scientific and technological excellence in research and therapy of leukemia (cml, aml, all, cll, mds, cmpd) by integration of the leading national leukemia networks and their interdisciplinary partner groups in europe

    harnessing the sun: europe and brazil strengthen ties in fusion research

    new predictive marker used in treatment of leukemia

    improving the scientific and technological research capacity of food institute on safety and technology of food packaging

    hs1 protein, a prognostic marker in chronic lymphocytic leukemia (cll)

    methylation status of ddit3 gene in chronic myeloid leukemia

    an epidemiological investigation of leukemia incidence between 2003 and 2007 in nanjing, china

    1st conference on international scientific cooperation – supporting research integration: global solutions for global problems

    risk factors associated with within-herd transmission of bovine leukemia virus on dairy farms in japan

    gene-based outcome prediction in multiple cohorts of pediatric t-cell acute lymphoblastic leukemia: a children's oncology group study

    pristimerin induces apoptosis in imatinib-resistant chronic myelogenous leukemia cells harboring t315i mutation by blocking nf-kappab signaling and depleting bcr-abl
    sqlGR (359,375)
    		 a
    a